![Chip Clark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chip Clark
Chairman at
IBIO, INC.
Net worth: 2 334 $ as of 31/08/2026
Profile
Mr. William D.
Clark is a Chief Executive Officer at Altido Therapeutics, Inc., an Independent Director at Aldeyra Therapeutics, Inc. and a Chairman at iBio, Inc. He is on the Board of Directors at Aldeyra Therapeutics, Inc. Mr. Clark was previously employed as a President & Chief Executive Officer by Vibrant Biomedicines, an Independent Director by Arsanis, Inc., a President, Chief Executive Officer & Director by Genocea Biosciences, Inc., a Principal by Care Capital LLC, a Secretary, Chief Business Officer & Senior VP by Vanda Pharmaceuticals, Inc., and a Head-Business Development by GlaxoSmithKline LLC.
He received his undergraduate degree from Harvard University and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IBIO, INC. 0.01% | 01/09/2026 | 1,838 ( 0.01% ) | 2 334 $ | 31/08/2026 |
Chip Clark active positions
| Companies | Position | Start |
|---|---|---|
| IBIO, INC. | Chairman | 01/11/2022 |
| ALDEYRA THERAPEUTICS, INC. | Director/Board Member | 17/04/2025 |
Former positions of Chip Clark
| Companies | Position | End |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Chief Executive Officer | 01/01/2022 |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Director/Board Member | 13/03/2019 |
| VANDA PHARMACEUTICALS INC. | Founder | 26/03/2010 |
Care Capital LLC
 Care Capital LLC Investment ManagersFinance Care capital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and specialty pharmaceuticals. It provides financing for growth and buyout capital transactions with an investment size of USD 5 - 20 million. | Private Equity Investor | 20/06/2005 |
Training of Chip Clark
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Care Capital LLC
Care Capital LLC Investment ManagersFinance Care capital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and specialty pharmaceuticals. It provides financing for growth and buyout capital transactions with an investment size of USD 5 - 20 million. | Finance |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Chip Clark
